Bharat Parenterals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 509.7 million compared to INR 523.1 million a year ago. Revenue was INR 512.8 million compared to INR 545 million a year ago. Net income was INR 24.9 million compared to INR 40.4 million a year ago. Basic earnings per share from continuing operations was INR 4.24 compared to INR 7.04 a year ago. Diluted earnings per share from continuing operations was INR 4.24 compared to INR 7.04 a year ago.
For the full year, sales was INR 2,179.8 million compared to INR 2,120.1 million a year ago. Revenue was INR 2,297.2 million compared to INR 2,197.9 million a year ago. Net income was INR 164.4 million compared to INR 210.5 million a year ago. Basic earnings per share from continuing operations was INR 28.4 compared to INR 36.67 a year ago. Diluted earnings per share from continuing operations was INR 28.4 compared to INR 36.67 a year ago.